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The success rates of coronary angioplasty for the treat-
ment of chronic total occlusions are less favorable than
for coronary stenosis. Therefore, a new laser guidewire
(LW) was designed to facilitate the crossing of chronic
total occlusions. We report on the results of a European
multicenter surveillance study, evaluating the laser
guidewire performance. Between May 1994 and July
1996, 345 patients (age 59 6 10 years, 291 men) with
chronic total occlusions were enrolled in 28 European
centers. The median age of occlusion was 29 weeks
(range 2 to 884), the occlusion length 19 6 10 mm. LW
recanalization was successful in 205 patients (59%). LW
perforation occurred in 73 patients (21%), with hemo-
dynamic consequences in 4 (1%). There were no deaths,
emergency coronary artery bypass graft surgery, or
Q-wave myocardial infarctions. In a multivariate regres-
sion analysis an occlusion age of <40 weeks (p 5
0.001, RR 5 1.34) and an occlusion length <30 mm
(p 5 0.01, RR 5 1.59) were independent predictors of
success. Results indicate that the LW is an effective and
safe tool in the treatment of chronic total occlusion re-
fractory to conventional guidewires. Q1997 by Ex-
cerpta Medica, Inc.
(Am J Cardiol 1997;80:1419–1423)
Chronic total occlusions remain the ‘‘enfant terri-ble’’ of coronary angioplasty, as the success rates
still lag behind those of angioplasty for coronary ste-
nosis.1–6 Because total occlusion is estimated to be
present in one third of the angioplasty population,7,8
an attempt was made to improve on the procedural
success rates in this specific patient category. Thus, a
steerable guidewire with forward debulking proper-
ties, the laser wire (LW), was developed. Following a
single center pilot study9 in May 1994, a multicenter
surveillance study evaluating the performance of the
Spectranetics Prima Total Occlusion System (Spectra-
netics, Colorado Springs, Colorado) was initiated. In
this report we discuss the final outcome of the Euro-
pean Multicenter TOTAL Surveillance Study, which
served as a preamble for the currently ongoing multi-
center randomized trial, the ‘‘TOTAL trial.’’
METHODS
The laser wire: The LW and the technique of the
LW procedure have been described elsewhere.10–12 In
short, the Prima Total Occlusion System consists of an
0.018-inch guidewire containing 12 silica fibers with a
45-mm diameter and a support catheter providing ad-
ditional coaxial backup support. Since its introduction
in 1993, the LW has been subject to a number of
technical improvements. It changed from a nonsteer-
able straight wire to a steerable guidewire, designed to
function as an exchange wire (model 018-003, gener-
ation 2B), which is the currently used model.
The laser: The laser was the Spectranetics CVX 300
XeCl excimer laser. The fluence typically used during
a LW procedure was 60 mJ/mm2, with a pulse repe-
tition rate of 25 Hz. If any resistance prohibited suf-
ficient wire progression, the pulse repetition rate was
increased to 40 Hz, thus increasing the LW ablation
rate. During pulse trains with a maximum of 5 seconds
the wire was gently advanced at a rate of up to 1 mm/s.
Patient population: Data of patients with a total
occlusion (Thrombolysis In Myocardial Infarction
[TIMI] trial 0 and I flow)13 existing for .2 weeks who
underwent a procedure using the LW were prospec-
tively collected. A written informed consent was ob-
tained from all patients, according to local medical
ethics committee recommendations. Lesions typically
unfavorable for an attempt at recanalization, such as
bridging collaterals or a major side branch originating
from the occlusion stump, were deliberately not ex-
cluded. However, a visible entry point and visualiza-
tion of the distal vessel through collateral flow were
mandatory. The study protocol did not provide restric-
tions as to whether an attempt with a mechanical
guidewire should be made before the LW attempt. All
data regarding clinical history, preprocedural angio-
graphic assessment, angioplasty procedure, and even-
tual serious adverse effects were recorded in a stan-
dard case report form. The reference diameter of the
From the Department of Coronary Diagnostics and Intervention, Tho-
raxcentre, Academic Hospital Dijkzigt, Rotterdam, The Netherlands.
Manuscript received March 5, 1997; revised manuscript received
and accepted August 14, 1997.
Address for reprints: Patrick W. Serruys, MD, PhD, Erasmus Uni-
versity, Bd 412, P.O. Box 1738, 3000 DR Rotterdam, The Nether-
lands.
* See appendix for list of participating investigators in the European
Multicenter Laser Guidewire Surveillance Study.
©1997 by Excerpta Medica, Inc. 0002-9149/97/$17.00 1419
All rights reserved. PII S0002-9149(97)00704-2
occluded segment and the length of occlusion were
determined by visual assessment.
Definitions: LW success was defined as angio-
graphic evidence of reaching the true lumen of any
branch distal to the occlusion. This was subdivided
into ‘‘total success,’’ meaning the LW reached the
true distal lumen, and ‘‘partial success,’’ referring to
patients in whom a combination of LW and mechan-
ical guidewire was used to achieve reconstitution with
the parent neolumen. Procedural success was defined
as an average diameter stenosis of ,50% in 2 orthog-
onal views at completion of the procedure. Clinical
success was defined as procedural success without
death, myocardial infarction, emergency coronary ar-
tery bypass graft surgery, or repeat percutaneous
transluminal coronary angioplasty during the hospital
stay.
Adjunctive angioplasty: After successful crossing of
a guidewire, the nature of the ensuing angioplasty was
at the discretion of the investigator. For excimer laser
coronary angioplasty (ELCA), the 1.4-, 1.7-, or
2.0-mm Vitesse (Spectranetics) rapid exchange coro-
nary catheters were available. For ELCA procedures it
was advised to use a saline flush. The removal of
contrast medium and blood before and during laser
activation diminishes vascular wall damage resulting
from fast expanding water vapor bubble formation
with subsequent shock wave formation14,15 and
thereby reduces the incidence of coronary dissec-
tion.16
Statistical analysis: A multivariate regression anal-
ysis using SAS statistical software was performed to
identify independent predictors of success. Incidents
with a p value #0.05 were considered significant.
RESULTS
Between May 1994 and July 1996, in 28 centers,
345 patients (age 59 6 10 years, 291 men, previous
myocardial infarction 217 [63%] with a TIMI 0 flow
[n 5 284] or TIMI I flow [n 5 61] coronary occlu-
sion) who were treated with the LW entered the study.
In 16% of cases (n 5 54), a previous failed attempt at
recanalization using mechanical wires was reported.
The median angiographic age of occlusion was 12
weeks (range 2 to 728) or 29 weeks (range 2 to 894)
according to clinical history (Figure 1). The occlusion
length was 19 6 10 mm (Table I). The enrollment per
center was #10 patients in 13 centers, 11 to 20 pa-
tients in 14 centers, and 66 patients in 1 center.
Wire success: None of the primary mechanical wire
attempts (n 5 182, median duration 15 minutes, range
1 to 135) were successful (Figure 2). In all patients, a
second attempt was performed using the LW, which
was successful in 105 (58%). In patients in whom the
LW was the primary guidewire (n 5 163, median
TABLE I Baseline Lesion Characteristics
No.(%)
Left anterior descending artery 125 (36)
Circumflex artery 51 (15)





Central funnel 125 (36)
Eccentric funnel 95 (28)
Blunt stump 125 (36)
Major side branch 126 (37)
Microcapillary refill 36 (10)
Age of occlusion (wk) Median (range)
Angiographic age (n 5 161) 12 (2–728)
Clinical age (n 5 174) 29 (2–894)
Lesion measurements (mm) (mean 6 SD)
Length of occlusion (n 5 198) 19 6 10*
Reference diameter (n 5 184) 2.84 6 0.55
*Range: 2 to 50 mm.
TIMI 5 Thrombolyis In Myocardial Infarction trial.
FIGURE 1. Distribution of
the angiographically docu-
mented age of occlusion.
As the distribution is ‘‘non-
normal,’’ the median (at
12 weeks), rather than the
mean age of occlusion, is
given.
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duration 25 minutes, range 1 to 180), the attempt was
successful in 100 cases (61%). From the 205 cases
successfully performed with the LW, 169 cases were
a ‘‘total success,’’ whereas in 36 cases (17.5%), a
combination of techniques was used (‘‘partial suc-
cess’’). As a result, the overall LW success rate was
59% (205 of 345 cases).
Statistical analysis: The following parameters were
entered in a multiple univariate analysis: the age of
occlusion, the occlusion length, the reference diame-
ter, the presence of a side branch originating from the
occlusion stump, the presence of bridging collaterals,
the funnel shape (central vs eccentric funnel, or a
blunt stump) and the location of the occlusion (left
anterior descending vs no left anterior descending). A
logrithmic transformation of the age of occlusion was
performed to compensate for skew due to a nonnormal
distribution of parameters. A multivariate regression
analysis of these variables indicated that the indepen-
dent predictors of success were clinical age of occlu-
sion (p 5 0.004) and the occlusion length (p 5
0.0004). When the analysis was repeated for only
patients with a TIMI 0 flow coronary occlusion, again
the clinical age of occlusion (p 5 0.005) and the
occlusion length (p 5 0.002) were independent pre-
dictors of success. The respective cutoff lines of suc-
cess were reached at the clinical age of occlusion of 40
weeks (crossing success 63% for age ,40 weeks vs
47% for age $40 weeks, p 5 0.012, RR 5 1.34) and
an occlusion length of 30 mm (crossing success 62%
for length ,30 mm vs 39% for length $30 mm, p 5
0.0013, RR 5 1.59).
Adjunctive angioplasty: An adjunctive angioplasty
was performed after successful crossing of the total
occlusion in all 205 patients. Of these, 194 were
successful (procedural success rate of 95%). Only a
minority of patients were treated with balloon angio-
plasty alone (23%). The remaining patients were
treated with ELCA and adjunctive balloon angioplasty
(n 5 78, 38%), whereas in another 78 patients, angio-
plasty was completed by implantation of $1 intra-
coronary stent (Table II). The overall procedure dura-
tion was 105 minutes (range 20 to 330).
Procedure-related complications: Noteworthy is the
relatively high number of LW perforations (n 5 73,
Table III) that were originally perceived as a reason to
terminate the procedure (n 5 56). In 4 patients (1.2%),
the wire position was mistakenly thought to be intralu-
minal. In these cases, the advancement of a device
over the LW caused extravasation of contrast medium
leading to tamponade, which in all patients could be
TABLE II Procedural Success of Adjunctive Angioplasty
Procedure No. Success (%)
LaLa 2 0 (0)
LaBa 47 40 (85)
LaLaBa 78 78 (100)
LaBaSt 40 39 (98)
LaLaBaSt 38 37 (97)
Total 205 194 (95)
LaBa 5 laser wire-assisted balloon angioplasty; LaLaBa 5 laser wire-assisted
laser and balloon angioplasty; LaBaSt 5 laser wire-assisted balloon angio-
plasty with stenting; LaLa 5 laser wire-assisted laser angioplasty; LaLaBaSt 5
laser wire-assisted laser and balloon angioplasty with stenting.




Wire stuck 27 (19)
Wire perforation 56 (39)
Wire fracture 1 (0.7)
Other 12 (9)
FIGURE 2. Breakdown of the
results. MW 5 initial attempt
at recanalization using a me-
chanical guidewire; LW1 5
initial attempt at recanaliza-
tion using a laser wire;
LW2 5 a second attempt at
recanalization using the laser
wire after a failed mechanical
attempt.
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treated by means of nonsurgical drainage. However,
because no clinical sequelae were reported resulting
from LW perforation, per se, LW perforation emerged
to be a more or less benign event, thus allowing for a
continuation of the procedure after withdrawal of the
wire into the proximal part of the coronary artery.
Serious adverse events: Serious adverse events
were reported in 12 patients (3.5%): 3 non–Q-wave
myocardial infarctions, 4 repeat percutaneous translu-
minal coronary angioplasties, 4 tamponades, and 1
LW malfunction. Of interest is the overall benign
character of these events, in the absence of Q-wave
myocardial infarction, emergency coronary artery by-
pass graft surgery, and death. As a result of these
adverse events, clinical success was obtained in 54%
of the original patient cohort.
DISCUSSION
Since the early days of angioplasty, despite the
introduction of various new mechanical devices,17–19
we have not witnessed a substantial improvement in
the success rates of recanalization of chronic total
occluded coronary arteries. The only exception to this
experience could be the results described by Kinoshita
et al,20 which were achieved with the Japanese ‘‘Ath-
lete’’ guidewire.
Although the baseline characteristics of our study
population indicated that the patient group was repre-
sentative of current coronary angioplasty practice, the
number of patients with a previous myocardial infarc-
tion was relatively high. As reported, 16% of the
patients had a previously failed mechanical attempt at
recanalization. In addition, in the study there was a
100% failure of primary mechanical attempts. Obvi-
ously, by the very nature of this device registry, cases
in which a mechanical guidewire attempt was success-
ful were not reported because in these cases the LW
was not used. However, we feel that an average 59%
success rate with the LW after a failed attempt with
any type of mechanical guidewire is an encouraging
development. Furthermore, it is conceivable that in a
number of cases a failed primary attempt with a me-
chanical wire, causing dissection, might have nega-
tively influenced the success rate of the LW during a
subsequent attempt.
In 4 patients a LW exit resulted in tamponade. In
all 4 this was due to the advancement of a catheter into
the free pericardial space. Therefore, it is strongly
recommended not to advance any device over the LW
before the intraluminal position of the wire tip has
been confirmed by angiography.
In this registry there was a marked absence of
serious adverse events. No LW-related deaths, Q-
wave myocardial infarction, or emergency coronary
artery bypass graft surgery have been reported, sug-
gesting that recanalization of total occlusions by using
a LW is a relatively safe procedure. Notwithstanding
the initially positive results with this new technology
in a notoriously difficult subset of patients, there are
some limitations to this study. Given the protocol
design, there was freedom in initial guidewire selec-
tion (mechanical wire, LW), without recording of the
intention to treat. Completion of a screening log was
not required. As a result, it could not be determined
what percentage of patients with chronic total occlu-
sions were enrolled in this study. Earlier, we demon-
strated the influence of a ‘‘learning curve,’’ showing
an increase in success rates of 50% to 85% in a single
center experience.12 Therefore, the inclusion of learn-
ing curve data (13 of the 28 participating centers
enrolled #10 patients) and the implementation of
technical changes in the LW during the study may
possibly interfere with the results and their just inter-
pretation. Finally, the limited collection of in-hospital
events, in the absence of an angiographic and/or elec-
trocardiography corelab, precludes the possibility of
determining the mid- and long-term condition and
prognosis of these patients. Therefore, a randomized
trial with intention to treat recorded by a central tele-
phone allocation center was initiated in 1995. This
trial, with extensive and prospective collection of clin-
ical and angiographic data, will be conducted by an
independent coordinating center with corelab facili-
ties.
APPENDIX
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Maranon,’’ Madrid, Spain: E. Garcia; Sahlgrenska University Hospital, Go¨ten-
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Netherlands: J. Ernst, H. Plokker; Universita¨tsklinik Essen, Essen, Germany: M.
Haude; Universita¨tsklinik Inselspital, Bern, Switzerland: B. Meier; Centro Cuore
Columbus, Milano, Italy: A. Colombo; St. Thomas, London, United Kingdom:
M. Webb-Peploe; UH Gasthuisberg, Leuven, Belgium: F. van der Werf; Clairval
Hospital, Marseille, France: H. Escojido; Franz Volhard Klinik, Berlin, Germany:
D.R. Waigand.
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